The microproteome of cancer: From invisibility to relevance

Iñaki Merino-Valverde1, Emanuela Greco1, María Abad1

  • 1Vall d'Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain.

Insights

Newly discovered microproteins, translated from previously non-coding DNA, regulate fundamental cellular processes. These small proteins show significant potential in understanding and treating cancer biology.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Genomic regions once deemed non-protein coding harbor small open reading frames (sORFs).
  • These sORFs are transcribed and translated into conserved microproteins, often smaller than 300 base pairs.
  • While many microproteins remain uncharacterized, they are known to be crucial for DNA repair, RNA processing, and metabolism regulation.

Purpose of the Study:

  • To review the emerging field of microproteins.
  • To explore the relevance of microproteins in cancer biology, referencing the hallmarks of cancer.
  • To identify microproteins implicated in cancer or likely to play a role.

Main Methods:

  • Literature review focusing on microproteins and cancer.
  • Classification of microproteins based on their known or potential roles in cancer hallmarks.
  • Synthesis of current knowledge on microprotein function and cancer implications.

Main Results:

  • A growing number of microproteins are implicated in fundamental cellular processes.
  • Several microproteins are already known to be involved in cancer development and progression.
  • Many other microproteins are predicted to play roles in cancer due to their functions.

Conclusions:

  • The field of microproteins is nascent but rapidly expanding.
  • Microproteins represent a new class of molecular regulators with significant clinical potential.
  • Further research into microproteins promises crucial insights into cancer biology and potential therapeutic strategies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.1K